The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility

Susan M. Watanabe, Viviana Simon, Natasha D. Durham, Brittney R. Kemp, Satoshi Machihara, Kimdar Sherefa Kemal, Binshan Shi, Brian Foley, Hongru Li, Benjamin K. Chen, Barbara Weiser, Harold Burger, Kathryn Anastos, Chaoping Chen, Carol A. Carter

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: The p6 region of the HIV-1 structural precursor polyprotein, Gag, contains two motifs, P7TAP11 and L35YPLXSL41, designated as late (L) domain-1 and -2, respectively. These motifs bind the ESCRT-I factor Tsg101 and the ESCRT adaptor Alix, respectively, and are critical for efficient budding of virus particles from the plasma membrane. L domain-2 is thought to be functionally redundant to PTAP. To identify possible other functions of L domain-2, we examined this motif in dominant viruses that emerged in a group of 14 women who had detectable levels of HIV-1 in both plasma and genital tract despite a history of current or previous antiretroviral therapy. Results: Remarkably, variants possessing mutations or rare polymorphisms in the highly conserved L domain-2 were identified in seven of these women. A mutation in a conserved residue (S40A) that does not reduce Gag interaction with Alix and therefore did not reduce budding efficiency was further investigated. This mutation causes a simultaneous change in the Pol reading frame but exhibits little deficiency in Gag processing and virion maturation. Whether introduced into the HIV-1 NL4-3 strain genome or a model protease (PR) precursor, S40A reduced production of mature PR. This same mutation also led to high level detection of two extended forms of PR that were fairly stable compared to the WT in the presence of IDV at various concentrations; one of the extended forms was effective in trans processing even at micromolar IDV. Conclusions: Our results indicate that L domain-2, considered redundant in vitro, can undergo mutations in vivo that significantly alter PR function. These may contribute fitness benefits in both the absence and presence of PR inhibitor.

Original languageEnglish (US)
Article number64
JournalRetrovirology
Volume13
Issue number1
DOIs
StatePublished - Sep 6 2016

Fingerprint

Protease Inhibitors
HIV-1
Peptide Hydrolases
Mutation
Virion
Endosomal Sorting Complexes Required for Transport
gag Gene Products
Reading Frames
Cell Membrane
Genome
Viruses
Therapeutics

Keywords

  • Anti-retroviral drugs
  • ESCRT
  • HIV Gag
  • HIV protease
  • Late domain
  • Protease inhibitors

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Watanabe, S. M., Simon, V., Durham, N. D., Kemp, B. R., Machihara, S., Kemal, K. S., ... Carter, C. A. (2016). The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility. Retrovirology, 13(1), [64]. https://doi.org/10.1186/s12977-016-0298-1

The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility. / Watanabe, Susan M.; Simon, Viviana; Durham, Natasha D.; Kemp, Brittney R.; Machihara, Satoshi; Kemal, Kimdar Sherefa; Shi, Binshan; Foley, Brian; Li, Hongru; Chen, Benjamin K.; Weiser, Barbara; Burger, Harold; Anastos, Kathryn; Chen, Chaoping; Carter, Carol A.

In: Retrovirology, Vol. 13, No. 1, 64, 06.09.2016.

Research output: Contribution to journalArticle

Watanabe, SM, Simon, V, Durham, ND, Kemp, BR, Machihara, S, Kemal, KS, Shi, B, Foley, B, Li, H, Chen, BK, Weiser, B, Burger, H, Anastos, K, Chen, C & Carter, CA 2016, 'The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility', Retrovirology, vol. 13, no. 1, 64. https://doi.org/10.1186/s12977-016-0298-1
Watanabe, Susan M. ; Simon, Viviana ; Durham, Natasha D. ; Kemp, Brittney R. ; Machihara, Satoshi ; Kemal, Kimdar Sherefa ; Shi, Binshan ; Foley, Brian ; Li, Hongru ; Chen, Benjamin K. ; Weiser, Barbara ; Burger, Harold ; Anastos, Kathryn ; Chen, Chaoping ; Carter, Carol A. / The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility. In: Retrovirology. 2016 ; Vol. 13, No. 1.
@article{37dc0a6f266944708b9178d855abf143,
title = "The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility",
abstract = "Background: The p6 region of the HIV-1 structural precursor polyprotein, Gag, contains two motifs, P7TAP11 and L35YPLXSL41, designated as late (L) domain-1 and -2, respectively. These motifs bind the ESCRT-I factor Tsg101 and the ESCRT adaptor Alix, respectively, and are critical for efficient budding of virus particles from the plasma membrane. L domain-2 is thought to be functionally redundant to PTAP. To identify possible other functions of L domain-2, we examined this motif in dominant viruses that emerged in a group of 14 women who had detectable levels of HIV-1 in both plasma and genital tract despite a history of current or previous antiretroviral therapy. Results: Remarkably, variants possessing mutations or rare polymorphisms in the highly conserved L domain-2 were identified in seven of these women. A mutation in a conserved residue (S40A) that does not reduce Gag interaction with Alix and therefore did not reduce budding efficiency was further investigated. This mutation causes a simultaneous change in the Pol reading frame but exhibits little deficiency in Gag processing and virion maturation. Whether introduced into the HIV-1 NL4-3 strain genome or a model protease (PR) precursor, S40A reduced production of mature PR. This same mutation also led to high level detection of two extended forms of PR that were fairly stable compared to the WT in the presence of IDV at various concentrations; one of the extended forms was effective in trans processing even at micromolar IDV. Conclusions: Our results indicate that L domain-2, considered redundant in vitro, can undergo mutations in vivo that significantly alter PR function. These may contribute fitness benefits in both the absence and presence of PR inhibitor.",
keywords = "Anti-retroviral drugs, ESCRT, HIV Gag, HIV protease, Late domain, Protease inhibitors",
author = "Watanabe, {Susan M.} and Viviana Simon and Durham, {Natasha D.} and Kemp, {Brittney R.} and Satoshi Machihara and Kemal, {Kimdar Sherefa} and Binshan Shi and Brian Foley and Hongru Li and Chen, {Benjamin K.} and Barbara Weiser and Harold Burger and Kathryn Anastos and Chaoping Chen and Carter, {Carol A.}",
year = "2016",
month = "9",
day = "6",
doi = "10.1186/s12977-016-0298-1",
language = "English (US)",
volume = "13",
journal = "Retrovirology",
issn = "1742-4690",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility

AU - Watanabe, Susan M.

AU - Simon, Viviana

AU - Durham, Natasha D.

AU - Kemp, Brittney R.

AU - Machihara, Satoshi

AU - Kemal, Kimdar Sherefa

AU - Shi, Binshan

AU - Foley, Brian

AU - Li, Hongru

AU - Chen, Benjamin K.

AU - Weiser, Barbara

AU - Burger, Harold

AU - Anastos, Kathryn

AU - Chen, Chaoping

AU - Carter, Carol A.

PY - 2016/9/6

Y1 - 2016/9/6

N2 - Background: The p6 region of the HIV-1 structural precursor polyprotein, Gag, contains two motifs, P7TAP11 and L35YPLXSL41, designated as late (L) domain-1 and -2, respectively. These motifs bind the ESCRT-I factor Tsg101 and the ESCRT adaptor Alix, respectively, and are critical for efficient budding of virus particles from the plasma membrane. L domain-2 is thought to be functionally redundant to PTAP. To identify possible other functions of L domain-2, we examined this motif in dominant viruses that emerged in a group of 14 women who had detectable levels of HIV-1 in both plasma and genital tract despite a history of current or previous antiretroviral therapy. Results: Remarkably, variants possessing mutations or rare polymorphisms in the highly conserved L domain-2 were identified in seven of these women. A mutation in a conserved residue (S40A) that does not reduce Gag interaction with Alix and therefore did not reduce budding efficiency was further investigated. This mutation causes a simultaneous change in the Pol reading frame but exhibits little deficiency in Gag processing and virion maturation. Whether introduced into the HIV-1 NL4-3 strain genome or a model protease (PR) precursor, S40A reduced production of mature PR. This same mutation also led to high level detection of two extended forms of PR that were fairly stable compared to the WT in the presence of IDV at various concentrations; one of the extended forms was effective in trans processing even at micromolar IDV. Conclusions: Our results indicate that L domain-2, considered redundant in vitro, can undergo mutations in vivo that significantly alter PR function. These may contribute fitness benefits in both the absence and presence of PR inhibitor.

AB - Background: The p6 region of the HIV-1 structural precursor polyprotein, Gag, contains two motifs, P7TAP11 and L35YPLXSL41, designated as late (L) domain-1 and -2, respectively. These motifs bind the ESCRT-I factor Tsg101 and the ESCRT adaptor Alix, respectively, and are critical for efficient budding of virus particles from the plasma membrane. L domain-2 is thought to be functionally redundant to PTAP. To identify possible other functions of L domain-2, we examined this motif in dominant viruses that emerged in a group of 14 women who had detectable levels of HIV-1 in both plasma and genital tract despite a history of current or previous antiretroviral therapy. Results: Remarkably, variants possessing mutations or rare polymorphisms in the highly conserved L domain-2 were identified in seven of these women. A mutation in a conserved residue (S40A) that does not reduce Gag interaction with Alix and therefore did not reduce budding efficiency was further investigated. This mutation causes a simultaneous change in the Pol reading frame but exhibits little deficiency in Gag processing and virion maturation. Whether introduced into the HIV-1 NL4-3 strain genome or a model protease (PR) precursor, S40A reduced production of mature PR. This same mutation also led to high level detection of two extended forms of PR that were fairly stable compared to the WT in the presence of IDV at various concentrations; one of the extended forms was effective in trans processing even at micromolar IDV. Conclusions: Our results indicate that L domain-2, considered redundant in vitro, can undergo mutations in vivo that significantly alter PR function. These may contribute fitness benefits in both the absence and presence of PR inhibitor.

KW - Anti-retroviral drugs

KW - ESCRT

KW - HIV Gag

KW - HIV protease

KW - Late domain

KW - Protease inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84985019817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84985019817&partnerID=8YFLogxK

U2 - 10.1186/s12977-016-0298-1

DO - 10.1186/s12977-016-0298-1

M3 - Article

C2 - 27600154

AN - SCOPUS:84985019817

VL - 13

JO - Retrovirology

JF - Retrovirology

SN - 1742-4690

IS - 1

M1 - 64

ER -